Bromide

Bromide

SCHEMBL2450382

C=C[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
TSHR P16473 2/20 0.39
HIF1A Q16665 1/20 0.38
ALOX15 P16050 2/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
AKT1 P31749 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphine SCHEMBL28255509 0.97 ALDH1A1 (0.38) ALDH1A1TSHRHIF1AALOX15KDM4E
SCHEMBL35319498 0.97 ALDH1A1 (0.41) ALDH1A1TSHRHIF1AALOX15KDM4E
Iodide SCHEMBL26969679 0.94 ALDH1A1 (0.39) ALDH1A1TSHRHIF1AALOX15KDM4E
Hydrochloric Acid SCHEMBL28633975 0.94 ALDH1A1 (0.39) ALDH1A1TSHRHIF1AALOX15KDM4E
Fluoride Ion SCHEMBL9405342 0.94 ALDH1A1 (0.39) ALDH1A1TSHRHIF1AALOX15KDM4E
SCHEMBL31634029 0.87 ALDH1A1 (0.35) ALDH1A1TSHRHIF1AALOX15KDM4E
Bromide SCHEMBL2448830 0.79 HIF1A (0.43) ALDH1A1TSHRHIF1AMAPTTDP1
Bromide SCHEMBL20555667 0.78 TSHR (0.39) ALDH1A1TSHRHIF1AALOX15KDM4E
Bromide SCHEMBL7877086 0.77 TSHR (0.35) ALDH1A1TSHRHIF1AALOX15
Bromide SCHEMBL7877084 0.77 TSHR (0.35) ALDH1A1TSHRHIF1AALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 396 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12589384-B2 Non-metal catalyst for synthesizing polycarbonate by CO2 and preparation method therefor WUHAN INSTITUTE OF TECHNOLOGY (CN) 2026-03-31 US claimed
EP-4673399-A1 A LIQUID PHASE EXFOLIATION METHOD AND AN EXFOLIATING MEDIUM Centrum pre vyuzitie pokrocilych materialov Slovenskej akademie vied, verejna vyskumna institucia (SK) 2026-01-07 EP claimed
WO-2024181933-A1 A LIQUID PHASE EXFOLIATION METHOD AND AN EXFOLIATING MEDIUM CENTRUM PRE VYUZITIE POKROCILYCH MATERIALOV SLOVENSKEJ AKADEMIE VIED, VEREJNA VYSKUMNA INSTITUCIA (SK) 2024-09-06 WO claimed
CN-114394991-B Method for catalytic synthesis of vinyl trichlorosilane 浙江锦华新材料股份有限公司 2024-08-13 CN claimed
CN-118373999-A Synthesis method of low-molecular-weight hydroxyl silicone oil with controllable molecular weight 上海普信高分子材料有限公司 2024-07-23 CN claimed
US-20230415138-A1 NON-METAL CATALYST FOR SYNTHESIZING POLYCARBONATE BY CO2 AND PREPARATION METHOD THEREFOR WUHAN INSTITUTE OF TECHNOLOGY (CN) 2023-12-28 US claimed
US-20230100363-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF ORCA HOLDINGS, LLC 2023-03-30 US claimed
CN-114933698-A For CO 2 Non-metal catalyst for synthesizing polycarbonate and preparation method thereof 武汉工程大学 2022-08-23 CN claimed
US-20220177666-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF ORCA HOLDINGS, LLC 2022-06-09 US claimed
CN-114394991-A Method for catalytically synthesizing vinyl trichlorosilane 浙江锦华新材料股份有限公司 2022-04-26 CN claimed
US-5563014-A SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT XEROX CORPORATION (US) 1996-10-08 US claimed
US-5531900-A FOR REMOVING NEGATIVELY CHARGED MACROMOLECULAR AND COLLOIDAL CONTAMINANATS UNIVERSITY OF ARIZONA (US) 1996-07-02 US claimed
US-5514505-A SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE XEROX CORPORATION (US) 1996-05-07 US claimed
US-5456767-A Polymerization activated by oxygen corrosion of ferrous metal forming protective coating PETROLITE CORPORATION (US) 1995-10-10 US claimed
EP-0615853-A1 Recording sheets containing phosphonium compounds XEROX CORPORATION (US) 1994-09-21 EP claimed
US-4859458-A Hair conditioning polymers containing alkoxylated nitrogen salts of sulfonic acid MORTON THIOKOL, INC. (US) 1989-08-22 US claimed
US-4842712-A LIQUID DISTRIBUTORS OF CELLULOSE LONG FIBER NONWOVEN FABRIC FUJI PHOTO FILM CO., LTD. (JP) 1989-06-27 US claimed
EP-0231033-A2 Device for measuring ion activity FUJI PHOTO FILM CO., LTD. (JP) 1987-08-05 EP claimed
US-4578267-A ALKOXYLATED NITROGEN SALTS MODIFIED ADDITION POLYMERS MORTON THIOKOL, INC. (US) 1986-03-25 US claimed
US-4401650-A Skin conditioning polymers containing alkoxylated nitrogen salts of sulfonic acid THIOKOL CORPORATION (US) 1983-08-30 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230100363-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF CNR2, CNR1, CDIPT ALDH1A1 3487/4885TSHR 4448/4885HIF1A 3495/4885
US-20220177666-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF CNR2, CNR1, CDIPT ALDH1A1 3487/4885TSHR 4448/4885HIF1A 3495/4885
US-12589384-B2 Non-metal catalyst for synthesizing polycarbonate by CO2 and preparation method therefor PIK3CD, PIK3C2B, PIK3C2A ALDH1A1 3553/4885TSHR 2488/4885HIF1A 697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.